PHILADELPHIA–(BUSINESS WIRE)–Aramark (NYSE: ARMK) announced that it has signed a definitive agreement to sell its Healthcare Technologies (HCT) business for $300 million to TRIMEDX.
“Today’s action is another demonstration of the clear and focused strategy we are following that has substantially elevated our operating performance and is driving Aramark’s success,” said Eric J. Foss,Chairman, President and CEO. “The divestiture of our Healthcare Technologies business will further focus our portfolio around our core food, facilities and uniforms businesses. I want to thank and congratulate our HCT team members for their contributions to Aramark and wish them continued success.”
Aramark’s Healthcare Technologies business, based in Charlotte, NC, is a leading provider of healthcare technology services in North America, providing innovative management programs for clinical equipment at more than 500 hospital and healthcare facilities. The business, acquired by Aramark in 2001,has been in operation for over 45 years and employs more than 1,500 technicians, engineers and program staff. Services include maintenance and refurbishment of high end imaging equipment.
“This transaction represents the latest step in our commitment to deliver sustainable shareholder value, while also increasing our financial flexibility,” Foss added. “We will use the majority of proceeds to strengthen our balance sheet through debt reduction and will also repurchase $50 million of shares after closing of the sale.”
The transaction is subject to customary closing conditions and regulatory approvals, and is expected to close in the fourth quarter of calendar 2018.
What does this transaction mean for the strategic options for your healthcare business?
Contact Paragon Ventures for more information. www.paragonventures.com 800-719-1555
